Effect of Recombinant Human Interferon α-2b Spray on Herpangina

PHASE4CompletedINTERVENTIONAL
Enrollment

668

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2018

Conditions
Herpangina
Interventions
DRUG

Recombinant Human Interferon α-2b Spray

Recombinant human interferon α-2b spray (trade name Jeferon, specifications: 1 million U/support, 10mL/support or 2 million U/support, 20mL/support, 2-8 ℃ dark storage and transportation), 1 million U/day, used for 3 days, observed to the 4th day (until the 96th hour).

DRUG

Ribavirin

Ribavirin Spray, spray once every 4-5 hours, 1-2 times a spray, used for 3 days, observed to the 4th day(until the 96th hour ).

Trial Locations (1)

201102

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
collaborator

Tianjin Sinobioway Biomedicine Co.Ltd.

UNKNOWN

collaborator

Hunan Children's Hospital

OTHER_GOV

collaborator

Children's Hospital of Chongqing Medical University

OTHER

collaborator

Yuying Children's Hospital of Wenzhou Medical University

OTHER

collaborator

Qilu Children's Hospital of Shandong University

OTHER

collaborator

Children's Hospital of Kaifeng City

UNKNOWN

collaborator

Shenzhen Children's Hospital

OTHER_GOV

collaborator

Zunyi Medical College

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

Anhui Provincial Children's Hospital

OTHER

lead

Children's Hospital of Fudan University

OTHER

NCT03266601 - Effect of Recombinant Human Interferon α-2b Spray on Herpangina | Biotech Hunter | Biotech Hunter